Publications by authors named "Lutz Bullesfeld"

Claim this Profile
F
Findings from transoesophageal echocardiographic follow-up after mitral transcatheter edge-to-edge repair.
Joanna Bartkowiak, Mohammad Kassar, Salomon J Brülisauer, Laura Bubulyte, Daryoush Samim

EuroIntervention· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrative echocardiographic assessment of patients with secondary mitral regurgitation undergoing transcatheter edge-to-edge repair.
Nicolas Brugger, Mohammad Kassar, George C M Siontis, Sonja Widmer, Taishi Okuno

Catheter Cardiovasc Interv· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Compassionate use of the PASCAL transcatheter mitral valve repair system for patients with severe mitral regurgitation: a multicentre, prospective, observational, first-in-man study.
Fabien Praz, Konstantinos Spargias, Michael Chrissoheris, Lutz Büllesfeld, Georg Nickenig

Lancet· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVR: a meta-analysis.
George C M Siontis, Peter Jüni, Thomas Pilgrim, Stefan Stortecky, Lutz Büllesfeld

J Am Coll Cardiol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of stent overlap on long-term clinical outcomes in patients treated with newer-generation drug-eluting stents.
Crochan J O'Sullivan, Giulio G Stefanini, Lorenz Räber, Dik Heg, Masanori Taniwaki

EuroIntervention· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First clinical experience with Celt ACD(®) : a femoral arterial puncture closure device.
Aftab Jan, Peter Crean, Lutz Bullesfeld, James Coleman, Eberhard Grube

J Interv Cardiol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second valve implantation for the treatment of a malpositioned transcatheter aortic valve.
Ênio E Guérios, Steffen Gloekler, Thomas Pilgrim, Stefan Stortecky, Lutz Büllesfeld

J Invasive Cardiol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term comparison of everolimus- and sirolimus-eluting stents in patients with acute coronary syndromes.
Bindu Kalesan, Giulio G Stefanini, Lorenz Räber, Mathieu Schmutz, Sandro Baumgartner

JACC Cardiovasc Interv· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcome and predictors for adverse events after transcatheter aortic valve implantation with the use of different devices and access routes.
Peter Wenaweser, Thomas Pilgrim, Nadja Roth, Alexander Kadner, Stefan Stortecky

Am Heart J· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial experience with paclitaxel-coated stents.
Eberhard Grube, Lutz Büllesfeld

J Interv Cardiol· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[State of treatment of coronary artery disease by drug releasing stents].
Ralf Müller, Lutz Büllesfeld, Ulrich Gerckens, Eberhard Grube

Herz· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis